Scheduled outpatient follow-up within 14 days of discharge did not significantly affect 30-day unplanned readmissions compared to follow-up at ≥15 days (P=0.36) or no scheduled follow-up (P=0.75).
Cohort (n=1,044)
No
Does timely outpatient follow-up (≤14 days) decrease 30-day unplanned hospital readmissions in patients discharged home?
Timely outpatient follow-up (≤14 days) after hospital discharge was not associated with a decrease in 30-day unplanned readmission rates compared to later or no scheduled follow-up.
p-value: p=0.36 and 0.75
It is widely believed that timely follow-up decreases hospital readmissions; however, the literature evaluating time to follow-up is limited. The authors conducted a retrospective analysis of patients discharged from a tertiary care academic medical center and evaluated the relationship between outpatient follow-up appointments made and 30-day unplanned readmissions. Of 1044 patients discharged home, 518 (49.6%) patients had scheduled follow-up ≤14 days after discharge, 52 (4.9%) patients were scheduled ≥15 days after discharge, and 474 (45.4%) had no scheduled follow-up. There was no statistical difference in 30-day readmissions between patients with follow-up within 14 days and those with follow-up 15 days or longer from discharge (P = .36) or between patients with follow-up within 14 days and those without scheduled follow-up (P = .75). The timing of postdischarge follow-up did not affect readmissions. Further research is needed to determine such factors and to prospectively study time to outpatient follow-up after discharge and the decrease in readmission rates.
Kashiwagi et al. (Wed,) conducted a cohort in Hospital discharge (n=1,044). Scheduled outpatient follow-up ≤14 days after discharge vs. Scheduled follow-up ≥15 days after discharge or no scheduled follow-up was evaluated on 30-day unplanned readmissions (p=0.36 and 0.75). Scheduled outpatient follow-up within 14 days of discharge did not significantly affect 30-day unplanned readmissions compared to follow-up at ≥15 days (P=0.36) or no scheduled follow-up (P=0.75).